Globus Medical
GMED
312 hedge funds and large institutions have $4.07B invested in Globus Medical in 2018 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 111 increasing their positions, 109 reducing their positions, and 30 closing their positions.
77% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 30
25% more capital invested
Capital invested by funds: $3.27B → $4.07B (+$804M)
13% more call options, than puts
Call options by funds: $11.6M | Put options by funds: $10.3M
8% more funds holding
Funds holding: 290 → 312 (+22)
2% more repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 109
0.98% more ownership
Funds ownership: 87.22% → 88.2% (+0.98%)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$45.3M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$18.4M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$15.3M |
| 4 |
BlackRock
New York
|
+$13.4M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$12.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCH
Freestone Capital Holdings
Seattle,
Washington
|
-$43.3M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$34.7M |
| 3 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
-$15M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$10.2M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$9.83M |
GMED Hedge Fund Activity: Q3 2018 in Review
312 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q3 2018, worth a combined $4.07B — up 25% from $3.27B a quarter earlier.
Buyers outnumbered sellers: 53 funds opened new GMED positions and 30 closed out — a net gain of 23 holders — while 111 added to existing stakes and 109 trimmed.
The largest buyer was Marshall Wace, opening a new position worth an estimated $45.3M. The largest seller was Freestone Capital Holdings, exiting entirely with an estimated $43.3M sold.
- 312 institutional investors held Globus Medical (GMED) as of Q3 2018, up from 290 in Q2 2018.
- Funds reported $4.07B of Globus Medical stock for Q3 2018, up 25% quarter-over-quarter.
- 53 funds opened new Globus Medical positions in Q3 2018 and 30 closed out, a net change of +23 holders.
- The largest Globus Medical buyer in Q3 2018 was Marshall Wace, an estimated $45.3M added.
- The largest Globus Medical seller in Q3 2018 was Freestone Capital Holdings, an estimated $43.3M sold.
Based on aggregated 13F filings for Q3 2018.